Show simple item record

dc.contributor.authorPonnusamy, Suriyan
dc.contributor.authorCoss, Christopher C.
dc.contributor.authorThiyagarajan, Thirumagal
dc.contributor.authorWatts, Kate
dc.contributor.authorHwang, Dong-Jin
dc.contributor.authorHe, Yali
dc.contributor.authorSelth, Luke A.
dc.contributor.authorMcEwan, Iain J.
dc.contributor.authorDuke, Charles B.
dc.contributor.authorPagadala, Jayaprakash
dc.contributor.authorSingh, Geetika
dc.contributor.authorWake, Robert W.
dc.contributor.authorLedbetter, Christopher
dc.contributor.authorTilley, Wayne D.
dc.contributor.authorMoldoveanu, Tudor
dc.contributor.authorDalton, James T.
dc.contributor.authorMiller, Duane D.
dc.contributor.authorNarayanan, Ramesh
dc.date.accessioned2018-10-03T23:07:11Z
dc.date.available2018-10-03T23:07:11Z
dc.date.issued2017-11
dc.identifier.citationPonnusamy , S , Coss , C C , Thiyagarajan , T , Watts , K , Hwang , D-J , He , Y , Selth , L A , McEwan , I J , Duke , C B , Pagadala , J , Singh , G , Wake , R W , Ledbetter , C , Tilley , W D , Moldoveanu , T , Dalton , J T , Miller , D D & Narayanan , R 2017 , ' Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer ' Cancer Research , vol. 77 , no. 22 , pp. 6282-6298 . DOI: 10.1158/0008-5472.CAN-17-0976en
dc.identifier.issn0008-5472
dc.identifier.otherPURE: 109594030
dc.identifier.otherPURE UUID: f9c915a6-d7ad-4215-88c0-426764aa2a3f
dc.identifier.otherScopus: 85033771016
dc.identifier.urihttp://hdl.handle.net/2164/11216
dc.descriptionAcknowledgements: The authors thank Mr. Maron Lee Barrett and Ms. Mayra Star for their technical help. The authors thank Dr. Dejian Ma for his technical help with the NMR studies. The authors thank the UTHSC and St. Jude NMR core for their help with the NMR studies. The authors thank Drs. Robert Getzenberg and Michael Mohler for providing useful comments on the manuscript. The authors thank Ms. Brandy Grimes for her help with tissue procurement. The authors thank Dr. Daniel Johnson of UT BioCore for microarray data analysis and Mr. Lorne Rose of UT-MRC core for microarray studies. Funding Source: The research presented in this manuscript was supported by a research funding provided by GTx, Inc. Memphis, TN to R. Narayanan and by a research funding provided by West Cancer Center to R. Narayanan.en
dc.format.extent17en
dc.language.isoeng
dc.relation.ispartofCancer Researchen
dc.rightsCopyright ©2017, American Association for Cancer Research. https://doi.org/10.1158/0008-5472.CAN-17-0976en
dc.subjectAndrogen Receptor (AR)en
dc.subjectSelective Androgen Receptor Degraders (SARDs)en
dc.subjectAR Splice Variants (AR-SV)en
dc.subjectprostate canceren
dc.subjectCastration-Resistant Prostate Cancer (CRPC)en
dc.subjectAR antagonisten
dc.subjectAF-1-binding AR antagonisten
dc.subjectAR translocation inhibitoren
dc.subjectAR pan-antagonisten
dc.subjectR Medicine (General)en
dc.subject.lccR1en
dc.titleNovel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Canceren
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen, Institute of Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen, Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPostprinten
dc.identifier.doihttps://doi.org/10.1158/0008-5472.CAN-17-0976
dc.date.embargoedUntil04-10-20


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record